Artiva Biotherapeutics (ARTV) Shares Outstanding (Weighted Average) (2023 - 2025)
Historic Shares Outstanding (Weighted Average) for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $24.5 million.
- Artiva Biotherapeutics' Shares Outstanding (Weighted Average) rose 2955.47% to $24.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.5 million, marking a year-over-year increase of 2955.47%. This contributed to the annual value of $11.3 million for FY2024, which is 130254.04% up from last year.
- Latest data reveals that Artiva Biotherapeutics reported Shares Outstanding (Weighted Average) of $24.5 million as of Q3 2025, which was up 2955.47% from $24.4 million recorded in Q2 2025.
- Artiva Biotherapeutics' Shares Outstanding (Weighted Average)'s 5-year high stood at $24.5 million during Q3 2025, with a 5-year trough of $800889.0 in Q2 2023.
- In the last 3 years, Artiva Biotherapeutics' Shares Outstanding (Weighted Average) had a median value of $6.0 million in 2024 and averaged $10.7 million.
- As far as peak fluctuations go, Artiva Biotherapeutics' Shares Outstanding (Weighted Average) surged by 128.87% in 2024, and later surged by 290608.06% in 2025.
- Over the past 3 years, Artiva Biotherapeutics' Shares Outstanding (Weighted Average) (Quarter) stood at $802747.0 in 2023, then soared by 1302.54% to $11.3 million in 2024, then skyrocketed by 117.44% to $24.5 million in 2025.
- Its Shares Outstanding (Weighted Average) was $24.5 million in Q3 2025, compared to $24.4 million in Q2 2025 and $24.3 million in Q1 2025.